Skip to main navigation Skip to search Skip to main content

A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics

  • Jacinda C. Abdul-Mutakabbir
  • , Elizabeth B. Hirsch
  • , Caroline Ko
  • , Britny R. Brown
  • , Aiman Bandali
  • , Jason Mordino
  • , Leah H. Yoke
  • , Taison Bell
  • , Talia H. Swartz
  • , Uzma Syed
  • , Matifadza Hlatshwayo
  • , Ila M. Saunders

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Article number100263
JournalThe Lancet Regional Health - Americas
Volume11
DOIs
StatePublished - Jul 2022

Bibliographical note

Funding Information:
JAM has received advisory board honoraria from Shionogi. EBH has received grant funding from Merck outside of the discussed topic, and advisory board honoraria from Merck, MeMed, and Melinta. US is a board member of the IDSA IDA&E Committee and Eid Holiday Coalition, and founder and CEO of Align Us inc. IMS has received advisory board honoraria from EUSA Pharma and serves on the Horizon CME Committee as a member and speaker. All other authors declare no relevant conflicts of interest or financial relationships.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this